Developing the Next Generation Female OAB Treatment Device

July 13, 2015

Amphora Medical Successfully Meets Clinical Requirement to Trigger Second Tranche of Series A Investment

July 13, 2015, Amphora Medical successfully meet the clinical goals to close on the second tranche of $6.4 Million of the $12.8 Million Series A financing, which initially closed on May 24, 2013.

The funds from the second tranche will be used to develop the next generation female OAB treatment device and study it in a feasibility trial in the United States.